Senator Mike Braun @SenatorBraun
FDA’s slow and overly burdensome regulatory pathways prevent patients with no treatment options and little time to wait from accessing a potentially life-saving drug—often driving them to OTHER countries for treatment. This is unacceptable. — PolitiTweet.org